Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC) [EARLY_Phase 1]
An EARLY_PHASE1 clinical trial is evaluating Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for relapsed or refractory non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer [NA]
A completed clinical trial evaluating the use of [18]F-FDG PET/CT as a non-invasive method for staging non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2017-02-20Clinical Trial Update: The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells [Phase 1]
Phase 1 clinical trial evaluating Dribbles antigen to activate T cells for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2017-02-17Clinical Trial Update: Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial is evaluating the combination of apatinib mesylate and pemetrexed in patients with pretreated advanced non-squamous non-smal…
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery [Phase 3]
A Phase 3 prognostic trial evaluating metastasis in surgically resectable stage I–III non-small cell lung cancer. Results from the study hav…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-02-15Clinical Trial Update: Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients [Phase 2]
A Phase 2 clinical trial update on adjuvant pembrolizumab for N2-positive stage IIIA non-small cell lung cancer; the current status of the t…
-
CLINICAL_TRIALS research · 2017-02-15Clinical Trial Update: Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction [NA]
This document is a clinical trial update evaluating MR-PET imaging for diagnosis, treatment outcomes, and prognosis prediction in non-small …
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating eribulin mesylate in combination with intermittent erlotinib in patients with previously treated advanced non-small…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Alimta (pemetrexed) as a single-agent therapy in patients with non-small cell lung cancer and poor performance stat…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research [Phase 3]
Phase 3 trial LUME-Columbus evaluating nintedanib plus docetaxel in advanced non-small cell lung cancer was terminated with results posted.
-
CLINICAL_TRIALS withdrawal · 2017-02-13Clinical Trial Update: Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 study of ibrutinib followed by ibrutinib in combination with nivolumab in non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI [Phase 2]
A Phase 2 clinical trial comparing pemetrexed plus cisplatin versus pemetrexed alone in non-small cell lung cancer patients who progressed a…
-
CLINICAL_TRIALS research · 2017-02-10Clinical Trial Update: Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial updating Apatinib in combination with EGFR-TKI for advanced EGFR-TKI-resistant non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma [Phase 4]
A Phase 4 trial update on icotinib as first-line and maintenance therapy for patients with EGFR-mutated non-small cell lung cancer (lung ade…
-
CLINICAL_TRIALS withdrawal · 2017-02-07Clinical Trial Update: MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases [Phase 2]
Phase 2 trial of MRI-guided High Intensity Focused Ultrasound (HIFU) with ThermoDox for palliation of painful bone metastases has been withd…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21 [Phase 2]
Phase II clinical trial evaluating Erlotinib with concurrent radiotherapy in unresectable non-small cell lung cancer harboring activating EG…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR [Phase 2]
A Phase 2 clinical trial is evaluating icotinib at different doses as second-line treatment for patients with non-small cell lung cancer and…
-
CLINICAL_TRIALS research · 2017-02-03Clinical Trial Update: Combined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line Treatment [Phase 2]
A Phase 2 clinical trial exploring the combined use of natural killer cell therapy with doublet chemotherapy as first-line treatment for adv…
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy [Phase 3]
Phase 3 trial investigating sunitinib malate as maintenance therapy after chemotherapy in stage IIIB/IV non-small cell lung cancer; study co…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC [Phase 2]
Phase 2 study evaluating cetuximab with radiation therapy followed by consolidation chemotherapy in non-small cell lung cancer; trial result…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma [EARLY_Phase 1]
This EARLY_PHASE1 feasibility trial evaluating SBRT plus chemotherapy for Stage I–II non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer [Phase 3]
This document notes the completion of a Phase 3 trial evaluating prevention of radiation pneumonitis after three-dimensional conformal radia…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine and carboplatin with or without AZD2171 as first-line therapy for stage IIIB/IV non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating pemetrexed disodium with or without sorafenib as second-line therapy in stage IIIB/IV non-small cell lung cancer ha…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations [Phase 1]
Phase 1 study evaluating intermittent, high-dose afatinib to determine the maximal tolerated dose and assess activity in non-small cell lung…